Barclays
ETRM

Barclays’s EnteroMedics Inc. ETRM Stock Holding History

Barclays’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-40
Closed – – 7412
2017
Q3 		$0 Buy
+40
New +$118 ﹤0.01% 7372
2017
Q2 		– Sell
-401
Closed -$2K – 7318
2017
Q1 		$2K Buy
+401
New +$2.96K ﹤0.01% 6539
2013
Q3 		– Sell
-89
Closed -$106K – 8003
2013
Q2 		$106K Buy
+89
New +$94K ﹤0.01% 5751

Other funds holding ETRM

SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Barclays's ETRM Position: Q4 2017 in Review

Barclays sold out of EnteroMedics Inc. (ETRM) in Q4 2017, closing a stake of 40 shares.

Barclays first reported a position in ETRM in Q2 2013 and held it in 3 quarters. The position peaked at $106K in Q2 2013. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.

  • Barclays reported no remaining EnteroMedics Inc. position as of Q4 2017 after selling out during the quarter.
  • Barclays sold 40 EnteroMedics Inc. shares in Q4 2017.
  • Barclays first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 3 quarters.
  • Barclays's EnteroMedics Inc. position peaked at $106K in Q2 2013.
  • 1 fund tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2017.

Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.